Will India benefit from two new covid therapies?

As Indian hospitals prepare for a likely surge in admissions of covid-19 patients, two new antiviral drugs—Nirmatrelvir and Molnupiravir—will expand the arsenal of tools available to doctors. Mint explains the promise that these new covid-19 therapies hold: 

from mint - Science https://ift.tt/34j2Lat
https://ift.tt/eA8V8J